15-90749562-AAC-A
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_000057.4(BLM):c.298_299delCA(p.Gln100GlufsTer42) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000743 in 1,614,068 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. Q100Q) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000057.4 frameshift
Scores
Clinical Significance
Conservation
Publications
- Bloom syndromeInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Myriad Women’s Health, Labcorp Genetics (formerly Invitae), G2P, Laboratory for Molecular Medicine, Orphanet, Genomics England PanelApp, ClinGen
- osteosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- breast cancerInheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
- hereditary nonpolyposis colon cancerInheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000057.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| BLM | NM_000057.4 | MANE Select | c.298_299delCA | p.Gln100GlufsTer42 | frameshift | Exon 3 of 22 | NP_000048.1 | ||
| BLM | NM_001287246.2 | c.298_299delCA | p.Gln100GlufsTer42 | frameshift | Exon 4 of 23 | NP_001274175.1 | |||
| BLM | NM_001287247.2 | c.298_299delCA | p.Gln100GlufsTer42 | frameshift | Exon 3 of 20 | NP_001274176.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| BLM | ENST00000355112.8 | TSL:1 MANE Select | c.298_299delCA | p.Gln100GlufsTer42 | frameshift | Exon 3 of 22 | ENSP00000347232.3 | ||
| BLM | ENST00000560509.5 | TSL:1 | c.298_299delCA | p.Gln100GlufsTer42 | frameshift | Exon 3 of 20 | ENSP00000454158.1 | ||
| BLM | ENST00000559724.5 | TSL:1 | n.298_299delCA | non_coding_transcript_exon | Exon 3 of 22 | ENSP00000453359.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152212Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000119 AC: 3AN: 251314 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.00000684 AC: 10AN: 1461856Hom.: 0 AF XY: 0.00000688 AC XY: 5AN XY: 727226 show subpopulations
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152212Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74368 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Bloom syndrome Pathogenic:4
This sequence change creates a premature translational stop signal (p.Gln100Glufs*42) in the BLM gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in BLM are known to be pathogenic (PMID: 17407155). This variant is present in population databases (rs745807085, gnomAD 0.006%). This premature translational stop signal has been observed in individual(s) with pancreatic ductal adenocarcinoma (PMID: 26546047). ClinVar contains an entry for this variant (Variation ID: 371569). For these reasons, this variant has been classified as Pathogenic.
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com.
Hereditary cancer-predisposing syndrome Pathogenic:2
The c.298_299delCA pathogenic mutation, located in coding exon 2 of the BLM gene, results from a deletion of two nucleotides at nucleotide positions 298 to 299, causing a translational frameshift with a predicted alternate stop codon (p.Q100Efs*42). This alteration was detected by whole exome sequencing in a pancreatic cancer patient and segregated in 2 out of 3 pancreatic cancer affected family members and/or obligate carriers; a predicted pathogenic alteration was also detected in the SPP1 gene in the proband (Smith AL et al. Cancer Lett. 2016 Jan 28;370(2):302-12). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.
not provided Pathogenic:1
Identified in a patient with personal and family history of pancreatic cancer (Smith et al., 2016); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 31589614, 29625052, 26546047)
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at